Acute kidney injury can occur with checkpoint inhibitors

Avoiding concurrent PPIs may be wise, say researchers

About 3% of cancer patients treated with immune-checkpoint inhibitors develop sustained acute kidney injury potentially due to their therapy, a retrospective study suggests.